Liaoning Green Biological Pharmaceutical Group Co., Ltd.

Using placebo as control, explore the effectiveness of different doses of PE-001 tablets in treating male subjects with premature ejaculation;

A randomized, double-blind, placebo- and active drug-controlled, multicenter Phase II clinical trial of the efficacy and safety of MT-1207 tablets in the treatment of mild and moderate essential hypertension

Primary purpose: To evaluate the tolerability of MT-1207 in patients with hypertension after multiple doses, single doses, and multiple administrations; To evaluate the pharmacokinetics of MT-1207 in patients with hypertension after multiple doses, single doses, and multiple administrations; Secondary purpose: To preliminarily evaluate the pharmacodynamics